Mario Negri Institute for Pharmacological Research

NCT07828054

Phase 3Not yet recruiting2026244 people18 Sept 2026clinicaltrials.gov

NCT07813858

CollaboratorPhase 2Not yet recruiting202687 people10 Sept 2026clinicaltrials.gov

NCT06158698

CollaboratorPhase 3Recruiting202380 people6 Dec 2023clinicaltrials.gov

Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS

Phase 2/3Recruiting2025246 people13 Nov 2023clinicaltrials.gov

NCT04794517

Phase 2Completed202132 people12 Mar 2021clinicaltrials.gov

NCT04143581

Phase 2Withdrawn20210 people29 Oct 2019clinicaltrials.gov

NCT03923842

CollaboratorPhase 2Status unknown201945 people23 Apr 2019clinicaltrials.gov

NCT03665350

Phase 2Terminated201810 people11 Sept 2018clinicaltrials.gov

NCT03654105

CollaboratorPhase 2Active, not recruiting20192,000 people31 Aug 2018clinicaltrials.gov

NCT03358017

Phase 2Completed201854 people30 Nov 2017clinicaltrials.gov

NCT02347163

Phase 2Terminated201522 people27 Jan 2015clinicaltrials.gov

NCT02338570

Phase 4Terminated201531 people14 Jan 2015clinicaltrials.gov

NCT01640782

Phase 3Completed20051,100 people16 Jul 2012clinicaltrials.gov

NCT01321255

CollaboratorPhase 3Completed20122,118 people23 Mar 2011clinicaltrials.gov

NCT01223755

Phase 2/3Terminated201041 people19 Oct 2010clinicaltrials.gov

NCT01086826

CollaboratorPhase 3Completed2008320 people15 Mar 2010clinicaltrials.gov

NCT01052389

Phase 4Completed2007300 people20 Jan 2010clinicaltrials.gov

NCT00984750

Phase 3Completed2008229 people25 Sept 2009clinicaltrials.gov

NCT00752479

Phase 1/2Terminated20084 people15 Sept 2008clinicaltrials.gov

NCT00505102

CollaboratorPhase 4Status unknown2007200 people20 Jul 2007clinicaltrials.gov